The Mitogen-Activated Protein Kinase Pathway for Molecular-Targeted Cancer Treatment
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-540-31209-3_9.pdf
Reference62 articles.
1. Ahn NG, Nahreini TS, Tolwinski NS, Resing KA (2001) Pharmacological inhibitors of MKK1 and MKK2. Methods Enzymol 332:417–431
2. Allen LF, Sebolt-Leopold J, Meyer MB (2003) CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin Oncol 30:105–116
3. Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanaandam G, Rapp U, Ashwort A, Marshall C, Cowley S (1994) Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 13:1610–1619
4. Baccarini M (2005) Second nature: biological functions of the Raf-1 “kinase”. FEBS Lett 579:3271–327
5. Beeram M, Patnaik A, Rowinsky EK (2005) Raf:a strategic target for therapeutic development against cancer. J Clin Oncol 23:6771–6790
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How oncogenic mutations activate human MAP kinase 1 (MEK1): a molecular dynamics simulation study;Journal of Biomolecular Structure and Dynamics;2019-11-06
2. Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells;Tumor Biology;2014-05-21
3. Synthesis and Biological Evaluation of RGD-Conjugated MEK1/2 Kinase Inhibitors for Integrin-Targeted Cancer Therapy;Molecules;2013-11-12
4. H2O2 preferentially synergizes with nitroprusside to induce apoptosis associated with superoxide dismutase dysregulation in human melanoma irrespective of p53 status: Antagonism by o-phenanthroline;Chemico-Biological Interactions;2010-10
5. Differential Up-regulation of MAP Kinase Phosphatases MKP3/DUSP6 and DUSP5 by Ets2 and c-Jun Converge in the Control of the Growth Arrest Versus Proliferation Response of MCF-7 Breast Cancer Cells to Phorbol Ester;Journal of Biological Chemistry;2010-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3